Product NDC: | 65649-241 |
Proprietary Name: | Azasan |
Non Proprietary Name: | AZATHIOPRINE |
Active Ingredient(s): | 100 mg/1 & nbsp; AZATHIOPRINE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65649-241 |
Labeler Name: | Salix Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075252 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030401 |
Package NDC: | 65649-241-41 |
Package Description: | 100 TABLET in 1 BOTTLE (65649-241-41) |
NDC Code | 65649-241-41 |
Proprietary Name | Azasan |
Package Description | 100 TABLET in 1 BOTTLE (65649-241-41) |
Product NDC | 65649-241 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | AZATHIOPRINE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20030401 |
Marketing Category Name | ANDA |
Labeler Name | Salix Pharmaceuticals, Inc. |
Substance Name | AZATHIOPRINE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Purine Antimetabolite [EPC],Purines [Chemical/Ingredient] |